Becton Dickinson and Co BDX

NYSE US Health Care

$181.97 ▼ -1.01% ($-1.86)

Index member: S&P 500

Open $182.51

Prev Close $183.83

Day Range $180.09 – $182.95

52W Range $127.59 – $193.07

Market Cap $48.82B

P/E (TTM) 52.36

Beta 0.24

Div Yield 1.59%

EPS (TTM) $3.31

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1963-09-25
Shares Out.	275,540,000
Website	bd.com/ ↗
Phone	12018476800
Employees	72,000
Revenue	$4.98B
Gross Profit	$2.32B
Net Income	$378.0M
Free Cash Flow	$2.53B
Total Assets	$50.73B
Total Liabilities	$26.32B
Equity	$24.42B

About Becton Dickinson and Co

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Becton Dickinson and Co is a publicly traded company under the ticker symbol BDX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.